CoSe2 nanoparticles catalyzed the formation of Cu-BTC polyhedral nanoframes enabling biosensing of endogenous opioid peptides

B Bharathi Natarajan (Independent Researcher 5 , Coimbatore, Tamil Nadu,) L Lu Lei (College of Biological, Chemical Sciences and Engineering, Jiaxing University 1 , Jiaxing, Zhejiang 314001,) P Palanisamy Kannan (College of Biological, Chemical Sciences and Engineering, Jiaxing University 1 , Jiaxing, Zhejiang 314001,) K Kanagaraj Rajalakshmi (School of Chemistry and Chemical Engineering, Jiangsu University 2 , Jiaxing, Zhenjiang 212013,) S Selvaraj Muthusamy Y Yuanguo Xu (School of Chemistry and Chemical Engineering, Jiangsu University 2 , Jiaxing, Zhenjiang 212013,)

Abstract

We describe a point-of-care biosensing platform for the detection of endogenous opioids using an integrated assay. In this system, cobalt–selenium (Co-Se2) nanoparticles catalyze the formation of tunable Cu-BTC metal–organic framework (MOF) nanostructures (Cu-BTC@Co-Sex:1MOFs), which serve as potential biosensing candidates. These Cu-BTC@Co-Sex:1MOFs are functionalized with mono-target (Anti-Met-Enk or Anti-Leu-Enk) and/or dual-target (Anti-Met-Enk/Leu-Enk) antibodies for the selective and simultaneous recognition of Met-Enkephalin (Met-Enk) and Leu-Enkephalin (Leu-Enk). Bovine serum albumin is employed as a blocking agent to minimize nonspecific binding, thereby enhancing the specificity and reproducibility of the biosensor and enabling the detection of Met-Enk and Leu-Enk within clinically relevant concentration ranges. Among various MOF configurations, the Cu-BTC@Co-Se3:1MOFs-based biosensing platform exhibits a broad detection range, 1.0–200.0 pg/mL for Met-Enk and 5.0–300.0 pg/mL for Leu-Enk covering physiological concentration ranges, with limits of detection of 0.81 and 3.64 pg/mL, respectively (S/N = 3). These performance characteristics are primarily attributed to the following: (i) a noticeable difference in isoelectric points between Cu-BTC@Co-Se3:1MOFs (≥8.61) and Anti-Met-Enk-Abs (∼4.94), which facilitates electrostatic interactions for effective antibody incorporation; (ii) the distribution of Co-Se2 nanoparticles within the MOF porous cavities and on the surface, providing a high active surface area (57.4 and 51.6 m2/g), which enables the efficient Anti-Met-Enk-Abs antibody immobilization; and (iii) ester-like bridging between antibody carboxyl groups and metal centers (Cu, Co, and Se) through chemical adsorption interactions. Finally, clinical validation with human serum and artificial mouse cerebrospinal fluid showed recovery rates of 90.6%–96.2%, comparable to those from a standard ELISA kit.

Article Details

Volume / Issue Vol. 127, Issue 3
Published July 21, 2025
ISSN 0003-6951
Publisher American Institute of Physics

Journal Info

Applied Physics Letters

American Institute of Physics

ISSN: 0003-6951 Physical Sciences

Authors (6)

B

Bharathi Natarajan

Independent Researcher 5 , Coimbatore, Tamil Nadu,

L

Lu Lei

College of Biological, Chemical Sciences and Engineering, Jiaxing University 1 , Jiaxing, Zhejiang 314001,

P

Palanisamy Kannan

College of Biological, Chemical Sciences and Engineering, Jiaxing University 1 , Jiaxing, Zhejiang 314001,

K

Kanagaraj Rajalakshmi

School of Chemistry and Chemical Engineering, Jiangsu University 2 , Jiaxing, Zhenjiang 212013,

S

Selvaraj Muthusamy

Y

Yuanguo Xu

School of Chemistry and Chemical Engineering, Jiangsu University 2 , Jiaxing, Zhenjiang 212013,